These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
659 related articles for article (PubMed ID: 21596768)
1. Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis. Beers DR; Henkel JS; Zhao W; Wang J; Huang A; Wen S; Liao B; Appel SH Brain; 2011 May; 134(Pt 5):1293-314. PubMed ID: 21596768 [TBL] [Abstract][Full Text] [Related]
2. Deleterious effects of lymphocytes at the early stage of neurodegeneration in an animal model of amyotrophic lateral sclerosis. Tada S; Okuno T; Yasui T; Nakatsuji Y; Sugimoto T; Kikutani H; Sakoda S J Neuroinflammation; 2011 Feb; 8():19. PubMed ID: 21345177 [TBL] [Abstract][Full Text] [Related]
3. Effect of thymic stimulation of CD4+ T cell expansion on disease onset and progression in mutant SOD1 mice. Sheean RK; Weston RH; Perera ND; D'Amico A; Nutt SL; Turner BJ J Neuroinflammation; 2015 Feb; 12():40. PubMed ID: 25889790 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of regulatory T lymphocytes and IL2Ra and FOXP3 gene expression in peripheral mononuclear cells from patients with amyotrophic lateral sclerosis. Rashid Chehreh Bargh S; Tafakhori A; Masoumi F; Rahmani F; Ahmadi M; Namdar A; Azimi M; Tavasolian P; Habibi S; Zamani B; Maserrat M; Sadr M; Noorbakhsh F; Rezaei N Ir J Med Sci; 2018 Nov; 187(4):1065-1071. PubMed ID: 29574662 [TBL] [Abstract][Full Text] [Related]
5. Association of Regulatory T-Cell Expansion With Progression of Amyotrophic Lateral Sclerosis: A Study of Humans and a Transgenic Mouse Model. Sheean RK; McKay FC; Cretney E; Bye CR; Perera ND; Tomas D; Weston RA; Scheller KJ; Djouma E; Menon P; Schibeci SD; Marmash N; Yerbury JJ; Nutt SL; Booth DR; Stewart GJ; Kiernan MC; Vucic S; Turner BJ JAMA Neurol; 2018 Jun; 75(6):681-689. PubMed ID: 29507931 [TBL] [Abstract][Full Text] [Related]
7. System xC- is a mediator of microglial function and its deletion slows symptoms in amyotrophic lateral sclerosis mice. Mesci P; Zaïdi S; Lobsiger CS; Millecamps S; Escartin C; Seilhean D; Sato H; Mallat M; Boillée S Brain; 2015 Jan; 138(Pt 1):53-68. PubMed ID: 25384799 [TBL] [Abstract][Full Text] [Related]
8. Regulatory T lymphocytes from ALS mice suppress microglia and effector T lymphocytes through different cytokine-mediated mechanisms. Zhao W; Beers DR; Liao B; Henkel JS; Appel SH Neurobiol Dis; 2012 Dec; 48(3):418-28. PubMed ID: 22820142 [TBL] [Abstract][Full Text] [Related]
11. Ablation of proliferating microglia does not affect motor neuron degeneration in amyotrophic lateral sclerosis caused by mutant superoxide dismutase. Gowing G; Philips T; Van Wijmeersch B; Audet JN; Dewil M; Van Den Bosch L; Billiau AD; Robberecht W; Julien JP J Neurosci; 2008 Oct; 28(41):10234-44. PubMed ID: 18842883 [TBL] [Abstract][Full Text] [Related]
12. Absence of toll-like receptor 4 (TLR4) extends survival in the hSOD1 G93A mouse model of amyotrophic lateral sclerosis. Lee JY; Lee JD; Phipps S; Noakes PG; Woodruff TM J Neuroinflammation; 2015 May; 12():90. PubMed ID: 25962427 [TBL] [Abstract][Full Text] [Related]
13. Transcriptomic indices of fast and slow disease progression in two mouse models of amyotrophic lateral sclerosis. Nardo G; Iennaco R; Fusi N; Heath PR; Marino M; Trolese MC; Ferraiuolo L; Lawrence N; Shaw PJ; Bendotti C Brain; 2013 Nov; 136(Pt 11):3305-32. PubMed ID: 24065725 [TBL] [Abstract][Full Text] [Related]
15. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model. Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002 [TBL] [Abstract][Full Text] [Related]
16. Progressive changes in microglia and macrophages in spinal cord and peripheral nerve in the transgenic rat model of amyotrophic lateral sclerosis. Graber DJ; Hickey WF; Harris BT J Neuroinflammation; 2010 Jan; 7():8. PubMed ID: 20109233 [TBL] [Abstract][Full Text] [Related]
17. Induction of proinflammatory molecules in mice with amyotrophic lateral sclerosis: no requirement for proapoptotic interleukin-1beta in neurodegeneration. Nguyen MD; Julien JP; Rivest S Ann Neurol; 2001 Nov; 50(5):630-9. PubMed ID: 11706969 [TBL] [Abstract][Full Text] [Related]
18. Fingolimod: A Disease-Modifier Drug in a Mouse Model of Amyotrophic Lateral Sclerosis. Potenza RL; De Simone R; Armida M; Mazziotti V; Pèzzola A; Popoli P; Minghetti L Neurotherapeutics; 2016 Oct; 13(4):918-927. PubMed ID: 27456702 [TBL] [Abstract][Full Text] [Related]
19. Blockade of gap junction hemichannel suppresses disease progression in mouse models of amyotrophic lateral sclerosis and Alzheimer's disease. Takeuchi H; Mizoguchi H; Doi Y; Jin S; Noda M; Liang J; Li H; Zhou Y; Mori R; Yasuoka S; Li E; Parajuli B; Kawanokuchi J; Sonobe Y; Sato J; Yamanaka K; Sobue G; Mizuno T; Suzumura A PLoS One; 2011; 6(6):e21108. PubMed ID: 21712989 [TBL] [Abstract][Full Text] [Related]
20. T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS. Chiu IM; Chen A; Zheng Y; Kosaras B; Tsiftsoglou SA; Vartanian TK; Brown RH; Carroll MC Proc Natl Acad Sci U S A; 2008 Nov; 105(46):17913-8. PubMed ID: 18997009 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]